Scotland · NHS Scotland MSAN
Pancreatic enzyme replacement therapy (PERT)
MSAN(2024)24 · Level 2 · issued 13 May 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Creon® 10,000 and 25,000 gastro-resistant capsules are in limited supply until 2026. | Limited supply | 2026 |
| 2. Nutrizym® 22 capsules are out of stock until mid-August 2024. | Out of stock | mid-August 2024 |
| 3. Pancrex V® capsules and powder remain available but are unable to support an increase in | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2024:24
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
979eddd8a7efd6d6a866847dfb93bc58e3d9b9a9e0ae2f9d586b2666450f818fsha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2024-24.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.